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Understanding the mechanisms of vaccine-elicited protection con-
tributes to the development of new vaccines. The emerging field of
systems vaccinology provides detailed information on host responses
to vaccination and has been successfully applied to study the
molecular mechanisms of several vaccines. Long noncoding RNAs
(lncRNAs) are crucially involved in multiple biological processes, but
their role in vaccine-induced immunity has not been explored. We
performed an analysis of over 2,000 blood transcriptome samples
from 17 vaccine cohorts to identify lncRNAs potentially involved with
antibody responses to influenza and yellow fever vaccines. We have
created an online database where all results from this analysis can
be accessed easily. We found that lncRNAs participate in distinct
immunological pathways related to vaccine-elicited responses. Among
them, we showed that the expression of lncRNA FAM30A was high
in B cells and correlates with the expression of immunoglobulin
genes located in its genomic vicinity. We also identified altered
expression of these lncRNAs in RNA-sequencing (RNA-seq) data
from a cohort of children following immunization with intranasal
live attenuated influenza vaccine, suggesting a common role across
several diverse vaccines. Taken together, these findings provide
evidence that lncRNAs have a significant impact on immune re-
sponses induced by vaccination.
systems biology | vaccination | transcriptome | long noncoding RNAs
Vaccines are among the greatest achievements of medicine,having greatly reduced the mortality and morbidity of many
major infectious diseases of mankind (1). However, our under-
standing of the molecular mechanisms involved in vaccine-
mediated protection remains incomplete (2). The emerging
field of systems vaccinology provides substantial new insights and
a new tool for testing and developing vaccines (2). This approach
has been applied to the study of immune responses induced by
yellow fever vaccination (3–5), influenza vaccination (6–13),
malaria (14), and herpes zoster vaccination (15) among others.
The human genome may transcribe over 100,000 long non-
coding RNAs (lncRNAs), which are defined as transcripts with
more than 200 nucleotides without detectable coding potential
(16). While initially considered transcriptional noise, lncRNAs
are increasingly linked to multiple biological processes ranging
from chromatin remodeling (17) to the regulation of splicing
patterns of transcripts (18). Moreover, several lncRNAs are
known to exert functions in immune-related cells and processes,
such as control of dendritic cell differentiation (19), cytokine
production (20), activation of CD8+ T cells (21), control of
Foxp3 expression in regulatory T cells (22), and CD4+ T cell
differentiation (23).
Systems vaccinology studies have focused solely on analyzing
the expression of genes that encode proteins. Only one of these
studies proposed that noncoding transcripts may play a role in
vaccine-induced immunity (7). Given the compelling body of
knowledge associating lncRNAs with immunological processes,
we hypothesized that they might also play a key role in vaccine-
induced immunity. Leveraging the fact that most microarray
platforms contain probes targeting lncRNAs (24, 25), we per-
formed a massive transcriptome analysis of 2,059 blood samples
from 17 cohorts of participants vaccinated with yellow fever or
influenza vaccine. Our analysis identified hundreds of lncRNAs
potentially involved with the immune responses elicited by these
vaccines. Specifically, we show herein that lncRNAs present re-
iterated changes in expression following vaccination and that
these changes are correlated to antibody production. We also
propose that vaccine-related lncRNAs may exert their activities
in distinct immunological pathways. Moreover, we used an RNA-
sequencing (RNA-seq) dataset to identify lncRNAs which were
induced or repressed after vaccination with a live attenuated
influenza vaccine (LAIV). Finally, we created an online database
that stores all of the results from our meta-analysis. Taken to-
gether, our findings reveal the potential roles of lncRNAs in
regulating the immune responses to vaccination.
Significance
Long noncoding RNAs (lncRNAs) are known to be involved in
several immunological processes. In spite of their general rel-
evance to human immunity, to date there are no reports on the
importance of lncRNAs in vaccine responses. Here we apply a
“systems vaccinology” framework to study the role of lncRNAs
in vaccine-mediated immunity. We applied meta-analytical ap-
proaches using public microarray data from over 2,000 blood
transcriptome samples of vaccinees and an RNA-sequencing
(RNA-seq) dataset from vaccinated children to tackle this ques-
tion. Our results indicate that lncRNAs are important players in
several immunological processes elicited by vaccination.
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Results
Vaccine Cohorts and Reannotation of Microarray Platforms. Blood
and peripheral blood mononuclear cell (PBMC) expression data
from 17 cohorts of human participants immunized with either
yellow fever vaccine (YF-17D) or inactivated influenza vaccine
(IV) were analyzed (Fig. 1A and SI Appendix, Table S1). Most of
these cohorts included antibody titer data collected before and
after vaccination (Fig. 1A). RNA derived from these samples was
hybridized onto microarrays, and raw data were deposited in the
Gene Expression Omnibus (GEO) and ArrayExpress databases.
After data preprocessing, four types of analyses for each dataset
were conducted to identify lncRNAs associated with vaccine-
induced immune responses (Fig. 1B and Methods).
To identify probes representing lncRNAs, the probe sequences
from each microarray platform were aligned to the human ge-
nome assembly hg38 and were reannotated based on genomic
features described in GENCODE version 24. All microarray plat-
forms contained probes targeting different classes of lncRNAs (Fig.
1C and SI Appendix, Fig. S1 A and B). Some probes that were
officially annotated by the microarray manufacturer as representing
protein-coding genes were, in reality, targeting antisense, intronic,
or intergenic lncRNAs (SI Appendix, Fig. S2). Since each micro-
array platform contains probes targeting specific sets of genes and
lncRNAs, we sought to characterize intersections between plat-
forms. A total of 204 and 91 lncRNAs were detected simulta-
neously in all microarray platforms used in IV and YF-17D vaccine
cohorts, respectively. These numbers increased when different
combinations of microarray platforms were considered (SI Appendix,
Fig. S1 A and B).
lncRNAs Present Coherent Changes of Expression after Vaccination.
Dozens of lncRNAs were identified whose expression was in-
duced or repressed after 1, 3, 7, or 14 d following IV compared
with baseline (Fig. 2A and SI Appendix, Fig. S3). Among the protein-coding genes, TNFRSF17, GGH, and CD38 were up-
regulated 7 d postvaccination in most cohorts (Fig. 2 B and C),
as previously reported (6). Gene set enrichment analysis (GSEA)
was performed for each comparison using blood transcription
modules (BTMs) (26). For IV, signatures related to monocytes,
cell cycle, TLR signaling, antigen presentation, and IFN re-
sponse were mostly induced on day 1 postvaccination, whereas a
strong signature associated with B cells and stimulated CD4+
T cells were detected in the majority of cohorts on day 7 post-
vaccination (SI Appendix, Fig. S4).
We also performed random-effects meta-analyses (27) to iden-
tify lncRNAs with coherent differential expression throughout the
IV and YF-17D cohorts. Often, lncRNAs showed subtle but sig-
nificant changes in expression following vaccination. For the IV
cohorts, MIAT and MCM3AP-AS1 were down-regulated on day
1 postvaccination (Fig. 2C) (nominal P values = 3.05 × 10−6 and
1.06 × 10−5, respectively). LINC01133 and DANCR were up-
regulated on day 3 (nominal P value = 0.000917) and on day 7
(nominal P value = 1.05 × 10−8) postvaccination, respectively
(Fig. 2C). As expected, the protein-coding gene TNFRSF17 was
up-regulated on day 7 post-IV in all cohorts (nominal P value =
1.787 × 10−11) (Fig. 2C). For YF-17D–vaccinated cohorts, dif-
ferentially expressed lncRNAs included AATBC (nominal P
value = 0.0008938 on day 7), MAPKAPK5-AS1 (nominal
P value = 0.0005284 on day 7), and LRRC75A-AS1 (nominal P
value = 0.000339 on day 3 and 2.524 × 10−8 on day 7). Increases
in the expression of IFN-stimulated genes after vaccination is a mark
of YF-17D response (3, 4). Accordingly, we detected sharp and
coherent increases in the expression of IFI27 in all YF-17D cohorts
on day 7 (nominal P value = 6.393 × 10−45) (SI Appendix, Fig. S5).
Next we investigated the expression of these lncRNAs in dif-
ferent immune-related cells using RNA-Seq data from Blueprint
(28) (see Methods, Fig. 2D, and SI Appendix, Fig. S4). DANCR,
which had previously been implicated in the control of histone
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Fig. 1. Experimental design of meta-analysis of 17 vaccine cohorts. (A)
Graphic representation of sampling regimen. Blood samples were collected
on days 0, 1, 3, 7, 14, and 28 after vaccination with IV or YF-17D. Numbers in
circles represent the number of samples used from each cohort after pro-
cessing. The Influenza season is shown in the name of the IV cohort (07 =
2007/2008, 08 = 2008/2009, etc.). (B) Summary of computational analyses
performed in this work. Blood transcriptome from cohorts was assessed with
commercial microarray platforms. After remapping of probes, each cohort
was subjected to analysis of differential expression, correlation to antibody
titers, correlation to neighboring genes, and coexpression analysis. (C)
Characterization of lncRNA classes represented in each microarray platform.
Fig. 2. Transcriptome analysis of cohorts immunized with inactivated IV.
Cumulative sum of differentially expressed lncRNAs (A) and protein-coding
genes (B) (y-axis) in one or more datasets (x-axis). Transcripts were consid-
ered differentially expressed if limma P values were lower than 0.05 in at
least three cohorts (for lncRNAs) or four cohorts (for protein-coding genes).
(C) Forest plots of representative lncRNAs and TNFRSF17 with reiterated
differential expression. Log2 fold changes with their corresponding 95%
confidence interval (x-axis) are plotted for each cohort (y-axis). Red vertical
lines and shaded regions represent log2 fold-change summaries and their
95% confidence intervals, respectively. (D) Heatmap depicting gene ex-
pression of human immune cells from ref. 28. Logs (FPKM) of genes are
scaled around zero. Columns represent samples; rows represent genes.
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methylation mediated by EZH2 (29, 30), is specifically expressed
in cells of lymphoid origin (Fig. 2D). The lncRNA AATBC,
which is associated with cell proliferation and apoptosis (31), was
expressed specifically in monocytes (SI Appendix, Fig. S5).
FAM30A lncRNA Levels Correlate with Those from Neighboring
Immunoglobulin Heavy Genes. We also identified lncRNAs
whose expression correlated with antibody response in both IV
and YF-17D cohorts. The lncRNA with the highest correlation
throughout all IV cohorts was FAM30A (KIAA0125), a lncRNA
embedded in the immunoglobulin (Ig) heavy (IgH) locus on
chromosome 14, in antisense orientation to IgH gene segments
(Fig. 3). The expression of FAM30A showed a positive correlation
to the levels of antibody titers on day 7 postvaccination in most of
the IV cohorts (Fig. 3A). Higher expression levels of FAM30A
were seen in B cells compared with other immune cell types (Fig.
3B). Increases in the frequency of antibody-secreting cells (ASCs)
could be observed 7 d post-IV (11, 13) and may partly explain the
observed positive correlation between FAM30A expression and
antibody titers seen in the microarray analysis. To check for evi-
dence of coregulation, we compared the expression levels of
FAM30A with those of 4 IgH locus genes located in its genomic
vicinity on day 7 post-IV. This approach revealed a strong positive
correlation with IgH gene segments (Fig. 3C), suggesting potential
related functions and a cis-regulatory role for FAM30A in regu-
lating the expression and functional organization of the gene
segments. We describe examples of lncRNAs whose expression is
inversely correlated with antibody responses in the SI Appendix.
Modular Expression Analyses of lncRNAs. Assessing gene coex-
pression patterns in blood transcriptome may help in the iden-
tification of novel functional connections between lncRNAs and
mRNAs after vaccination (32). To detect shared coexpression
patterns between IV cohorts, we first ran CEMiTool (33) in each
cohort using samples from baseline to day 7 after vaccination.
Next we integrated the resulting modules into a consensus net-
work and used a spin glass method to identify 16 cohesive net-
work subgroups (34), hereafter referred as communities (Fig.
4A). These communities were enriched for distinct immune-
related cells and processes such as monocytes (CM1), platelet
activation (CM4), T cells (CM5), IFN response (CM6), B cells
(CM7), and natural killer cells (CM9) (Fig. 4B). GSEAs were
then undertaken using the communities as gene sets and mean
log2 baseline-normalized fold change from all IV cohorts as ranks.
This approach revealed that communities displayed congruent
expression patterns between different cohorts in equivalent com-
parisons. For example, genes from CM1, CM3, and CM6 were
highly induced on day 1 postvaccination, whereas those from CM7
and CM8 were induced on day 7 postvaccination (Fig. 4C).
Network communities contained dozens of lncRNAs (SI Ap-
pendix, Table S2). Meticulous examination of genes connecting
to these lncRNAs may unveil potential transregulatory rela-
tionships (see SI Appendix). For instance, lncRNA PRKCQ-AS1
is a member of the T cell–related community CM5 in the IV
network (Fig. 4A). GSEA revealed that CM5 is consistently
down-regulated on day 1 after IV in all IV cohorts (Fig. 4C). A
subnetwork of genes connected to PRKCQ-AS1 is also broadly
down-regulated on day 1 (Fig. 4D). Several members of this
subnetwork are well-known T cell–related genes, such as CCR7,
CD27, ITK, LEF1, THEMIS, and SKAP1. These findings sug-
gest that PRKCQ-AS1 may be involved with T cell functions.
The same modular analysis was performed with YF-17D co-
horts, which resulted in 17 network communities (SI Appendix,
Fig. S6). Several lncRNAs were found within communities re-
lated to “chemokines in myeloid cells,” “T cell differentiation,”
and “platelet activation” (SI Appendix, Fig. S6). GSEA revealed
that, while activation of IFN response was restricted to days 1
and 3 post-IV (CM6 in Fig. 4C), a strong activation of IFN re-
sponse was still observed on day 7 in the YF network (CM2 in SI
Appendix, Fig. S6C).
Differential Expression of lncRNAs in RNA-Seq Data Generated from a
New Pediatric Vaccine Cohort. As RNA-seq analyzes the whole
transcriptome, it has the ability to discover lncRNAs associated
with vaccination. We assessed whether lncRNAs were differen-
tially expressed in an RNA-seq dataset of 26 children aged 2–4 y
old immunized with intranasal LAIV. Vaccination induced dif-
ferential expression of 55 lncRNAs in whole blood at day 2 post-
LAIV compared with baseline, with a false discovery rate (FDR)
threshold of 0.05 (SI Appendix, Fig. S7). Several lncRNAs found
in our meta-analyses were also found among differentially
expressed genes in this cohort, including FAM225A, LRRC75A-
AS1, MAPKAPK5-AS1, DANCR, and DICER-AS1.
VaccineDB: A Systems Vaccinology Database. We developed a user-
friendly online database named VaccineDB (https://vaccinedb.sysbio.
tools/) to catalog and organize the information generated in
this work. By selecting the vaccine (IV or YF-17D), the type of
analysis (differential expression, gene-antibody correlation, gene-
lncRNA correlation), and gene symbol identifiers, the database
displays one forest plot for each time point after vaccination
(SI Appendix, Fig. S8). The differential expression and gene-
antibody correlation analyses show, respectively, the expression
changes and the antibody correlation values of user-input protein-
coding genes or lncRNAs after either IV or YF-17D (SI Appendix,
Fig. S8). The database also displays the correlation between the
expression of a user-provided protein-coding gene and lncRNAs
within the same genomic region. This approach may help identify
lncRNAs with coordinated expression and potential regulatory cis-
acting roles in response to vaccination. Finally, to verify if the
Fig. 3. FAM30A expression correlates to antibody production and to gene
segments within the IgH locus. (A) Correlations between FAM30A and an-
tibody titers with corresponding 95% confidence interval (x-axis) are plotted
for each cohort (y-axis). Red vertical line and shaded region represent the
correlation summary and its 95% confidence interval, respectively. (B)
FAM30A expression is higher in B cells according to ref. 28. (C) Fold-change
correlation between FAM30A and gene segments within the IgH locus at day
7 after inactivated IV. Each circle represents Pearson correlation coefficient in
different IV cohorts. Meta-analysis P values are represented below cohort
identifiers.
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lncRNA is associated with known SNPs, the database displays the
genomic locus of the lncRNA and all SNPs from the dbSNP da-
tabase located there.
Discussion
Multiple orchestrated processes are involved in the immune re-
sponse to vaccination and infection. Our analyses have revealed
that lncRNAs may be linked to some of these processes. While
YF-17D contains a live attenuated yellow fever virus that needs
to replicate before priming the immune system of naïve indi-
viduals, IV contains proteins of the influenza virus that boost a
preexisting immunity. At day 7 postvaccination, the blood sig-
nature of YF-17D vaccinees is related to innate antiviral IFN
responses (3), whereas the signature of IV vaccines is more as-
sociated with antibody-secreting B cells (6, 7). These differences
may explain the distinct set of lncRNAs associated with each
vaccine. Nevertheless, we have still identified some commonly
induced lncRNAs which may reflect underlying common path-
ways in successful generation of vaccine-induced immunity.
LncRNA transcripts whose functions have been described in
other contexts, such as MIAT, LINC01133, and DANCR, were
found to be consistently differentially expressed in multiple
vaccination cohorts. MIAT, also known as Gomafu, was first
described in 2006 as a transcript harboring SNPs conferring in-
creased susceptibility to myocardial infarction (35). More recent
reports have shown that MIAT might be involved in processes
related to apoptosis, proliferation, oncogenesis, and cellular
migration by several mechanisms (reviewed in ref. 36). Consis-
tent down-regulation 1 d after IV across multiple cohorts may
point to an unappreciated role for MIAT in the early immune
response to vaccines. LINC01133 expression was found to be
increased in several cancers (37–39). In our analysis, LINC01133
was found to be up-regulated at day 3 after IV, which suggests that it
may also act to regulate immune cell proliferation following vacci-
nation. A role for lncRNAs in adaptive immune responses also needs
consideration. For example, DANCR, which was also up-regulated in
young vaccine responders at day 7, as discussed in a previous pub-
lication (12), was found to influence the activity of Enhancer of Zeste
Homolog 2 (EZH2) in multiple cancer types (29, 30, 40). Epigenetic
modifications mediated by EZH2 have been shown to affect B cell
differentiation and antibody production in mice (41). DANCR up-
regulation 7 d after IV suggests that it takes part in regulating the
differentiation of antibody-secreting cells, whose frequency in pe-
ripheral blood rises at roughly 7 d after IV (11, 13).
Other lncRNAs, such asMCM3AP-AS1, MAPKAPK5-AS1, and
LRRC75A-AS1, are still understudied. Nevertheless, their geno-
mic position might give clues to their potential target genes. For
example, MCM3AP encodes germinal center–associated nuclear
protein (GANP), which is related to antigen-specific B cell pro-
liferation in germinal centers (42). Down-regulation ofMCM3AP-
AS1 1 d after IV may point toward a role for this transcript in B
cell activity. MAPKAPK5 encodes a serine/threonine kinase that
activates heat shock protein 27, which has been associated with
replication of viruses (43). Down-regulation ofMAPKAPK5-AS1 7
d after YF-17D and 2 d after LAIV suggests a potential role for
this transcript in replication of attenuated viral vaccines. Further-
more, down-regulation of LRRC75A-AS1 at days 1 and 7 after YF-
17D (SI Appendix, Fig. S4), day 2 after LAIV (SI Appendix, Fig. S7),
and day 1 after IV (SI Appendix, Fig. S8) suggests a common role
for this lncRNA in response to more than one vaccine.
By correlating changes in gene expression with fold increases
in antibody titers following IV, we identified FAM30A, a tran-
script in antisense orientation in relation to gene segments from
the IgH locus. FAM30A was first described as a cDNA expressed
Fig. 4. Influenza vaccination consensus network. (A) The consensus network was constructed by intersecting CEMiTool results from all IV cohorts and pri-
oritizing frequently detected edges. Inference of communities was performed using a spin glass clustering algorithm. Graph colors are based on community
assignment. Each community is represented by a rectangle containing its name and the number of genes and lncRNAs (in parentheses). (B) Over-
representation analysis of selected communities using blood transcriptional modules (BTMs). False discovery rates (FDR) (x-axis) are plotted for each BTM. (C)
Gene set enrichment analysis (GSEA) performed with network communities (rows) and mean fold changes of all vaccinees from each cohort as ranks (col-
umns). Heat map represents normalized enrichment scores (NESs) of communities whose FDR < 0.05. (D) Some PRKCQ-AS1 connections within CM5. The colors
of nodes represent log2 fold-change summaries on day 1 relative to baseline.
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in the KG-1 cell line, spleen, and peripheral blood (44). Anti-
sense noncoding expression within murine loci poised for re-
combination has been reported in mice (45–47). Although
conclusive functional characterizations of these mouse lncRNAs are
still lacking, they were proposed to act in the regulation of variable
(diversity) joining [V(D)J] recombination by mediating long-range
DNA interactions between Ig segments (46). Network analysis also
revealed that FAM30A is a member of CM7, a community associ-
ated with B cell–related genes (Fig. 4B and SI Appendix, Table S2).
Altogether, our results indicate that FAM30A is probably related
to the biology of B lymphocytes and to antibody responses elicited
by IV. Although FAM30A is not conserved in mice, therefore
preventing murine studies, its association with immune responses
to vaccination warrants further investigation. Because microRNAs
(48–50) and linc-MAF-4 (51), a long intergenic noncoding RNA,
can be used as biomarkers of lymphocyte activation and differ-
entiation, we propose that FAM30A could be useful to quickly
monitor the antibody responses induced by influenza vaccination.
The limitations of this study must be mentioned. Since probes
from different manufacturers may be designed to target different
regions of the same gene, heterogeneity in expression between
cohorts might occur due to differential exon usage. Moreover, the
occurrence of correlations between pairs of neighboring genes is
not definitive evidence for the existence of regulatory relationships
(52). Our findings thus suggest the existence of regulatory func-
tions, but are not definitive evidence for such activities. Further
functional validation experiments are required (53).
To the best of our knowledge, there is no study focusing on the
role of lncRNAs during vaccine-induced immunity. The work
presented herein implicates lncRNAs in the regulation of spe-
cific processes associated with vaccination. We have also created
an online database where users can submit personalized queries
for coding genes and lncRNAs to visualize the results from our
meta-analyses. We hope that this comprehensive resource will
aid researchers in rapidly assessing hypotheses related to the
blood transcriptomics of human vaccines.
Methods
See SI Appendix, Supplementary Materials and Methods, for details and
additional references.
Vaccination of Human Subjects and Data Collection. Datasets with participants
immunizedwith inactivated IVs or with YF-17Dwere used (SI Appendix, Table
S1). PBMCs or whole blood microarray data from young adult subjects
(20–49 y), which were collected before and after vaccination, were downloaded
from GEO (https://www.ncbi.nlm.nih.gov/geo/) and ArrayExpress (https://
www.ebi.ac.uk/arrayexpress/).
Microarray Platform Reannotation Pipeline. We developed a Snakemake
pipeline to update probe annotations from microarray platforms. Probe
sequences were aligned against the HG38 assembly of the human ge-
nome using BLAT (54) with thresholds of alignment scores > 90% and
identity scores > 90%. Probes with multiple alignments were discarded, and
remaining probes were reassigned to gene feature annotations provided by
Gencode version 24 using BEDTools (55). Probes aligning with more than
one feature were also discarded.
Vaccination with Live Attenuation Influenza Vaccine and RNA Sequencing.
Children aged 2–4 y old (n = 52) were immunized with Russian-backbone
intranasal LAIV (Serum Institute of India Pvt Ltd) and RNA extracted from
whole blood collected in PAXgene tubes taken at baseline and at day 2 after
vaccination (clinicaltrials.gov identifier NCT02972957). This study was ap-
proved by The Gambia Government and UK Medical Research Council joint
ethics committee and the Medicines Control Agency of The Gambia, and it
was done according to International Conference on Harmonisation Good
Clinical Practice standards. A parent provided written or thumbprinted in-
formed consent for their child or children to participate. If parents were not
English-literate, an impartial witness was present throughout the informed
consent discussion undertaken in a local language, who signed to confirm
completeness of the consent provided. Library preparation and RNA se-
quencing (Illumina Hiseq X; 100-bp paired-end reads) were performed at the
Beijing Genome Institute. Quality control of raw sequencing data was
performed using FastQC. Mapping to the human reference genome
(GRCh38) was done using DART (56) (version 1.3.0). For each sample, histo-
grams of distance (within tile) between wells of all duplicate alignments
were evaluated. A distance of 2,500 pixels was appropriate to filter out likely
exclusion amplification duplicates. Picard MarkDuplicates was used to
remove these duplicates. Reads were counted at gene level using featur-
eCounts (57) via the wrapper R package Rsubread. Raw and processed data
are available in the GEO database (GSE128224).
Differential Expression.Differential expression analysis was conducted using a
moderated t test provided by the limma package (58). Comparisons were
performed between expression values from days 1, 3, 7, and 14 after vac-
cination and day 0 (baseline). Analyses were paired by subject and per-
formed separately for each cohort. The edgeR package (59) was used in the
differential expression analysis conducted with RNA-seq data from children
vaccinated with LAIV.
Correlation with Immune Parameters. Antibody titers, assessed with either
hemagglutination-inhibition assay (HAI) or microneutralization assay (MN),
were retrieved from microarray databases or supplemental materials from ar-
ticles. Antibody titer fold increases from each subject between day 28, 63, or 70
after vaccination and baseline values were log-transformed. Pairwise log2 fold-
change values for each day after vaccination (compared with baseline) were
correlated (Pearson’s correlation) with corresponding antibody titer fold
increases.
Correlation of Coding and Neighboring Noncoding Transcripts. A catalog of
lncRNA-mRNA genomic neighboring pairs was assembled using the
GenomicRanges package (60). Pairwise log2 fold-change values for each day
after vaccination compared with baseline of neighboring pairs were corre-
lated (Pearson correlation) to infer potential cis-regulatory regions.
Random-Effects Meta-Analyses. Effect sizes from differential expression
analysis, neighboring gene pair correlation analysis, and antibody titer cor-
relation analysis were integrated using random-effects models for meta-
analyses, as implemented in the metafor package (27). Limma log2 fold
changes from each study and their corresponding variances were submitted to
the rma function for estimation of summarized effect sizes using restricted
maximum likelihood (REML). For correlation-based analyses, sampling vari-
ances of Pearson correlation coefficients (PCCs) from each study were esti-
mated using the escalc function. Then PCCs and variances were submitted to
the rma function for estimation of summarized effect sizes using Hunter and
Schmidt (HS). Studies were weighted by the inverse of variance.
Building of a Consensus Network. Samples collected between days 0 and 7
after IV were submitted to CEMiTool using default parameters (Pearson
correlation coefficient and unbiased selection of genes by a variance-based
filter) (33). Genes from each module were connected between themselves to
create fully connected subnetworks for each cohort. The Pearson correlation
coefficient between each pair of genes (edge) in each cohort was then
computed.
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